chlorhexidine has been researched along with acyclovir in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Barak, S; Ben-Yehuda, A; Danon, Y; Katz, J; Marmary, I | 1 |
| Cherrick, HM; Min, BM; Park, JB; Park, NH | 1 |
| Bercy, P; De Beule, F; Ferrant, A | 1 |
| Alimohammadi, N; Kalachandra, S; Tallury, P | 1 |
| Kalachandra, S; Preisser, JS; Randall, MK; Tallury, P; Thaw, KL | 1 |
| Airrabeelli, R; Kalachandra, S; Li, J; Paquette, D; Tallury, P | 1 |
8 other study(ies) available for chlorhexidine and acyclovir
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Primary herpetic gingivostomatitis: no longer a disease of childhood?
Topics: Acyclovir; Adolescent; Adult; Chlorhexidine; Female; Humans; Israel; Lidocaine; Male; Miconazole; Military Personnel; Penicillin V; Stomatitis, Herpetic; Tonsillitis | 1991 |
Combined synergistic antiherpetic effect of acyclovir and chlorhexidine in vitro.
Topics: Acyclovir; Animals; Chlorhexidine; Chlorocebus aethiops; DNA, Viral; Drug Synergism; Simplexvirus; Vero Cells; Virus Replication | 1991 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin | 1991 |
Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
Topics: Acyclovir; Anti-Infective Agents, Local; Antiviral Agents; Calorimetry, Differential Scanning; Chlorhexidine; Coated Materials, Biocompatible; Drug Combinations; Drug Delivery Systems; Pharmaceutical Preparations, Dental; Polyethylenes; Polyvinyls; Statistics, Nonparametric | 2007 |
Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer.
Topics: Acyclovir; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Antiviral Agents; Chlorhexidine; Delayed-Action Preparations; Linear Models; Materials Testing; Micelles; Nystatin; Polyethylene Glycols; Polysorbates; Polyvinyls; Solubility; Surface-Active Agents | 2007 |
Release of antimicrobial and antiviral drugs from methacrylate copolymer system: effect of copolymer molecular weight and drug loading on drug release.
Topics: Acyclovir; Anti-Infective Agents, Local; Antiviral Agents; Biocompatible Materials; Calorimetry, Differential Scanning; Chlorhexidine; Chromatography, Gel; Composite Resins; Delayed-Action Preparations; Diffusion; Drug Carriers; Humans; Magnetic Resonance Spectroscopy; Materials Testing; Methacrylates; Methylmethacrylates; Molecular Weight; Spectrophotometry; Transition Temperature | 2008 |